# A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis

> **NCT02684240** · PHASE2 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 30 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **DRUG:** Nitazoxanide
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT02684240
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2018-04-11
- **Final completion:** 2018-04-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02684240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02684240, "A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02684240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*